Analytical Data
-
基因名
FGF3
- Application
-
别名
HBGF3; INT2; Heparin-binding growth factor 3; Murine Mammary Tumor Virus Integration Site(v-int-2)Oncogene Homolog; INT-2 Proto-Oncogene Protein; Proto-oncogene Int-2
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P11487
-
表达区间
Ala18~His239
-
蛋白长度
Partial
-
分子量
33kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Fibroblast growth factor 3 (FGF3) is a member of the fibroblast growth factor family, which plays a critical role in various biological processes, including cell proliferation, differentiation, and survival. FGF3 is particularly important in embryonic development, particularly in the formation of the inner ear and skeletal systems. Abnormal expression of FGF3 has been implicated in several diseases, including cancer, as it can influence tumor growth and metastasis. In recent years, research has increasingly focused on recombinant FGF3 protein due to its potential therapeutic applications. By producing FGF3 in a recombinant form, scientists can study its functional properties in detail, develop targeted therapies, and investigate its role in pathology. The ability to generate recombinant FGF3 allows for the exploration of its signaling pathways, interaction with receptors, and effects on cellular behavior. Moreover, these studies may lead to advances in regenerative medicine and targeted therapies aimed at mitigating the adverse effects associated with its dysregulation. Overall, the research on recombinant FGF3 protein is at the intersection of developmental biology and therapeutic innovation, highlighting its significant potential in both understanding fundamental biological processes and developing new treatment strategies for FGF3-related disorders.
